A detailed history of Raleigh Capital Management Inc. transactions in Organon & Co. stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 231 shares of OGN stock, worth $3,446. This represents 0.0% of its overall portfolio holdings.

Number of Shares
231
Previous 231 -0.0%
Holding current value
$3,446
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 22, 2023

BUY
$21.42 - $32.08 $4,948 - $7,410
231 New
231 $5,000
Q3 2022

Nov 09, 2022

BUY
$23.4 - $34.25 $1,708 - $2,500
73 Added 66.36%
183 $4,000
Q2 2022

Aug 30, 2022

BUY
$31.66 - $38.9 $31 - $38
1 Added 0.92%
110 $4,000
Q1 2022

May 12, 2022

SELL
$30.45 - $39.36 $274 - $354
-9 Reduced 7.63%
109 $4,000
Q4 2021

Feb 16, 2022

BUY
$28.67 - $37.13 $3,383 - $4,381
118 New
118 $4,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.79B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Raleigh Capital Management Inc. Portfolio

Follow Raleigh Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raleigh Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raleigh Capital Management Inc. with notifications on news.